Thursday Morning Live Cases: Coronary and Structural Interventions
Emory Percutaneous Intervention Course
93 videos
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided...
Read More
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided training for thousands of interventional cardiologists from the United States and abroad since 1981.
The meeting’s mission is to engage interventional cardiologists and cardiac surgeons specializing in coronary and structural heart disease to further enhance the care of their patients, mentor and train future generations of cardiovascular specialists, and lead front-line clinical research in the field.
Speakers
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally...
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and...
Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and graduate school at Vanderbilt University and then went to medical school at the University of South Florida College of Medicine. Dr. Harvey then did his residency training in Internal Medicine at Emory University Hospital in Atlanta, GA and completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at the Cleveland Clinic in Cleveland, OH where he served as the chief interventional fellow. Board-certified in Cardiovascular Medicine and Interventional Cardiology, Dr. Harvey has a special interest in structural and valvular heart disease, complex coronary artery disease, and mechanical cardiovascular circulatory support. He is the Director of the Cardiac Catheterization Laboratory and the Structural Heart Program at WellSpan York Hospital. He also serves as a member of the Executive Council for the Pennsylvania Chapter of the American College of Cardiology.
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional...
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Dr. Rinaldi is board certified in cardiology and specializes in interventional cardiology and vascular medicine. He...
Dr. Rinaldi is board certified in cardiology and specializes in interventional cardiology and vascular medicine. He is recognized as a national and international thought leader and an expert in the fields of coronary, peripheral and structural heart interventions, including transcatheter mitral valve repair and replacement, transcatheter aortic valve replacement, transcatheter tricuspid valve repair and left atrial appendage occlusion. He is the medical director of the Structural Heart Program at Atrium Health Sanger Heart & Vascular Institute, a professor of medicine at the University of North Carolina and a faculty member of The International Andreas Gruentzig Society. He formerly served for a decade as the medical director of research of the Structural Heart Program. Dr. Rinaldi has been recognized as a Top Doctor by the Charlotte Business Journal and Physician of the Quarter by Atrium Health Carolinas Medical Center. He is a member of the Alpha Omega Alpha Honor Medical Society. As the medical director of research at Sanger Heart & Vascular Institute for 10 years, he has served as a principal or sub investigator for numerous clinical trials involving thousands of patients. His current research interests include transcatheter mitral, aortic, tricuspid valve therapies, including novel devices and techniques through clinical trials and research.
Join the conversation
beautiful cases